Literature DB >> 16861696

E3-targeted anti-TRPC5 antibody inhibits store-operated calcium entry in freshly isolated pial arterioles.

Shang-Zhong Xu1, Guylain Boulay, Richard Flemming, David J Beech.   

Abstract

Smooth muscle cells in arterioles have pivotal roles in the determination of blood pressure and distribution of local blood flow. The cells exhibit calcium entry in response to passive store depletion, but the mechanisms and relevance of this phenomenon are poorly understood. Previously, a role for canonical transient receptor potential 1 (TRPC1) was indicated, but heterologous expression studies showed TRPC1 to have poor function in isolation, suggesting a requirement for additional proteins. Here we test the hypothesis that TRPC5 is such an additional protein, because TRPC5 forms heteromultimeric channels with TRPC1, and RNA encoding TRPC5 is present in arterioles. Recordings were from arteriolar fragments freshly isolated from rabbit pial membrane. Ionic current in response to store depletion has properties like that of the TRPC1/TRPC5 heteromultimer, and so the effect of the E3-targeted, externally acting, anti-TRPC5 blocking antibody (T5E3) was explored. T5E3 suppressed calcium entry in store-depleted arterioles but had no effect in the absence of store depletion. T5E3 preadsorbed to its antigenic peptide did not inhibit calcium entry. TRPC6 is commonly detected in smooth muscle and is present in the arterioles, but T5E3 had no effect on TRPC6. The data suggest that calcium entry occurring in response to passive store depletion in smooth muscle cells of arterioles involves TRPC5 as well as TRPC1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861696     DOI: 10.1152/ajpheart.00495.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  48 in total

Review 1.  The closing and opening of TRPC channels by Homer1 and STIM1.

Authors:  J P Yuan; K P Lee; J H Hong; S Muallem
Journal:  Acta Physiol (Oxf)       Date:  2011-05-27       Impact factor: 6.311

Review 2.  Inositol trisphosphate receptors in smooth muscle cells.

Authors:  Damodaran Narayanan; Adebowale Adebiyi; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 3.  Mechanism and functional significance of TRPC channel multimerization.

Authors:  Mitchel L Villereal
Journal:  Semin Cell Dev Biol       Date:  2006-11-01       Impact factor: 7.727

Review 4.  Store-operated calcium entry in vascular smooth muscle.

Authors:  F P Leung; L M Yung; X Yao; I Laher; Y Huang
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 5.  Multiple activation mechanisms of store-operated TRPC channels in smooth muscle cells.

Authors:  A P Albert; S N Saleh; C M Peppiatt-Wildman; W A Large
Journal:  J Physiol       Date:  2007-07-05       Impact factor: 5.182

6.  Production of a specific extracellular inhibitor of TRPM3 channels.

Authors:  J Naylor; C J Milligan; F Zeng; C Jones; D J Beech
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

Review 7.  Calcium Channels in Vascular Smooth Muscle.

Authors:  D Ghosh; A U Syed; M P Prada; M A Nystoriak; L F Santana; M Nieves-Cintrón; M F Navedo
Journal:  Adv Pharmacol       Date:  2016-10-14

Review 8.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

9.  IP3 constricts cerebral arteries via IP3 receptor-mediated TRPC3 channel activation and independently of sarcoplasmic reticulum Ca2+ release.

Authors:  Qi Xi; Adebowale Adebiyi; Guiling Zhao; Kenneth E Chapman; Christopher M Waters; Aviv Hassid; Jonathan H Jaggar
Journal:  Circ Res       Date:  2008-04-03       Impact factor: 17.367

Review 10.  Transient receptor potential channel C5 in cancer chemoresistance.

Authors:  Dong-xu He; Xin Ma
Journal:  Acta Pharmacol Sin       Date:  2015-12-14       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.